Men who have asymptomatic subclinical vascular disease are more likely to develop erectile dysfunction than men who don’t have early stage vascular disease, according to research presented at the American Heart Association’s Scientific Sessions 2014. Data suggests use of a coronary computed tomography (CT) calcium exam may reveal the patient’s risk of developing erectile dysfunction

The U.S. Food and Drug Administration (FDA) today cleared HeartFlow’s FFR-CT (fractional flow reserve—computed tomography) software, which permits non-invasive evaluation of coronary artery blood flow in patients showing signs of coronary artery disease.  
 
Philips Healthcare has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its IQon Spectral computed tomography (CT) technology for spectral imaging. It adds a new dimension to CT imaging, delivering anatomical information and offering the ability to characterize structures based on their material content within a single scan. The enhanced image quality may help improve confidence in diagnoses and deliver operational efficiency.
 

AZE Technology announced the U.S. Food and Drug Administration (FDA) approval of Phoenix (Volume Registration Viewer), a viewer developed with a new concept for efficient and accurate image interpretation. 

The Society of Cardiovascular Computed Tomography (SCCT) has published an update of the "SCCT Guidelines for the Interpretation and Reporting of Coronary CT Angiography: A Report of the Society of Cardiovascular Computed Tomography Guidelines Committee" document.
 

AZE Technology announced the U.S. Food and Drug Administration (FDA) approval of Phoenix (Volume Registration Viewer), a viewer developed with a completely new concept for efficient and accurate image interpretation.

Subscribe Now